U.S. Transfusion Diagnostics Market: Immunohematology and NAT Testing--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, Emerging Opportunities

This new report is a strategic analysis prepared in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies. 
 
Rationale

During the next five years, the US blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. 

The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications.

Strategic Recommendations

- New product development opportunities with significant market appeal.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.

The report explores future marketing and technological trends in the US; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years.

Blood Typing and Grouping Tests

ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin,
Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s),
Antiglobulin (Direct, C3 + IgG, IgG,  C3),
Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du).

Infectious Disease Screening Tests

AIDS (HIV NAT, HIV-1/2), Cytomegalovirus,
Hepatitis (HAV NAT, HBV NAT, HBs Ag,  
Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT,
Syphilis, West Nile Virus NAT.

Sales and Market Share Analysis

Sales and market share estimates of leading
suppliers of blood banking of reagents
and instruments, by individual product.

Competitive Assessments

Strategic assessments of major suppliers and
emerging market entrants, including their sales,
product portfolios, marketing tactics, and new
products in R&D.

Market Segmentation Analysis

- Comprehensive market segmentation
analysis, including review of the market
dynamics, trends, structure, size, growth,
and key suppliers.

- Test volume and sales forecasts for over 40
blood banking tests, including NAT, by market segment:

- Blood Centers
- Plasma Fractionation Facilities
- Hospitals
- Commercial/Private Laboratories
- Military Blood Banks

Current and Emerging Products

- Analysis of current and emerging blood banking tests.

- Review of automated and semi-automated
analyzers, including their operating
characteristics, features, and selling prices.

Technology Review

- Assessment of current and emerging technologies,
and their potential applications for the blood banking market.

- Comprehensive lists of companies developing
or marketing new technologies and products by test.

I. Introduction
II. Major Product Development Opportunities
A. Blood Typing and Grouping
B. Infectious Disease Screening
C. Auxiliary
III. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
IV. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection

V. Worldwide Technology and Market Overview
A. Major Blood Typing, Grouping and Infectious
Disease Screening Tests
1. Blood Typing and Grouping Tests
a. ABO
b. Antibody Panels
c. Antibody Screening
d. Antigen Typing
e. Antiglobulin Test
(continues)
f. Crossmatch
g. HLA Typing
h. Rh
i. Other Blood Groups
2. Infectious Disease Screening Tests
a. AIDS/HIV
- Background
- Diagnostic Tests
Enzyme Immunoassay
Viral Load/Drug Resistance Testing
Genotype and Phenotype Testing
- Blood Banking Considerations
b. Hepatitis Markers
- Hepatitis A
- Hepatitis B
- Hepatitis C
- Hepatitis D (Delta Hepatitis)
- Hepatitis E
- Hepatitis G
- Vaccines and Drugs
c. Cytomegalovirus
- Background
- Diagnostic Tests
- Vaccines and Drugs
d. Syphilis
- Background
- Diagnostic Tests
- Vaccines and Drugs
e. West Nile Virus
- Background
- Clinical Syndromes
- Diagnostic Tests
- Vaccines and Drugs
f. Parvovirus B19
- Microbiology
- Epidemiology
- Clinical Syndromes
- Diagnostic Test
- Vaccines and Drugs
(continues)
g. Creutzfeldt-Jakobs Disease
- Background
- Transmission
- Diagnostic Tests
- Vaccines and Drugs
h. Malaria
i. Chagas Disease
j. Babesiosis
3. Pathogen Reduction
4. Leukocyte Reduction
- Background
- Methods
B. Instrumentation Review: Operating Characteristics,
Features and Selling Prices of Leading Blood Typing,
Grouping and Infectious Disease Screening Automated
and Semiautomated Analyzers
C. Major Blood Banking Technologies
and Their Potential Applications
1. Molecular Diagnostics
2. Monoclonal and Polyclonal Antibodies
3. Immunoassays
4. Microtitration Plates
5. IT and Automation
6. Lasers
7. Robotics
8. Synthetic Red Cell Substitutes
9. Genetically Engineered Blood Components
10. Blood Preservation
11. Autologous Blood Transfusion/Freezing
VI. USA Blood Banking Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, by Market Segment,
Major Supplier Sales and Market Shares
(continues)
VII. Competitive Assessments
- Abbott
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- BioMerieux
- Bio-Rad
- CellMark Forensics/LabCorp
- Diagast
- DiaSorin
- Fujirebio
- Hologic/Gen-Probe
- Grifols
- Immucor
- Ortho-Clinical Diagnostics
- Proteome Sciences
- Quest Diagnostics
- Quidel
- Roche
- Siemens
- Tecan

List Of Tables

Major Companies Developing or Marketing
Blood Typing and Grouping Tests
Major Companies Developing or Marketing
HLA Typing Tests
Major Companies Developing or Marketing
AIDS Tests
Major Companies Developing or Marketing
Hepatitis Tests
Major Companies Developing or Marketing
CMV Tests
Major Companies Developing or Marketing
Syphilis Tests
Major Companies Developing or Marketing
Blood Bank Analyzers
Executive Summary Table: U.S.A., Total Blood Bank
Test Volume and Reagent Sales Forecast
by Test Category
U.S.A., Estimated Number of Inpatient and
Ambulatory Surgeries
U.S.A., Facilities Performing Blood
Bank Tests by Market Segment
U.S.A., Hospital Laboratories Performing
Blood Bank Tests by Bed Size
U.S.A., Commercial/Private Laboratories
Performing Blood Bank Tests
by Annual Test Volume Forecast
U.S.A., Facilities Collecting Whole Blood
And Plasma by Market Forecast Segment
(continues)
U.S.A., Whole Blood and Plasma Collections
By Market Forecast Segment
U.S.A., All Market Segments Blood Typing
and Grouping Test Volume by Market Forecast
Segment
U.S.A., All Market Segments Blood Typing
And Grouping Test Volume Forecast
U.S.A., Hospital Laboratories Blood
Typing and Grouping Test Volume Forecast
U.S.A., Community and Regional Blood Centers
Blood Typing and Grouping Test Volume Forecast
U.S.A., Commercial/Private Laboratories
Blood Typing and Grouping Test Volume Forecast
U.S.A., Plasma Fractionation Centers Blood
Typing and Grouping Test Volume Forecast
U.S.A., Military Blood Banks Blood Typing
and Grouping Test Volume Forecast
U.S.A., All Market Segments Infectious
Disease Screening Test Volume Forecast
By Market Segment
U.S.A., All Market Segments Infectious
Disease Screening Test Volume Forecast
U.S.A., Community and Regional Centers
Infectious Disease Screening Test Volume Forecast
U.S.A., Plasma Fractionation Centers
Infectious Disease Screening Test Volume Forecast
U.S.A., Hospital Blood Banks
Infectious Disease Screening Test Volume Forecast
U.S.A., Military Blood Banks Infectious
Disease Screening Test Volume Forecast
(continues)
U.S.A., All Market Segments Blood Typing
And Grouping Reagent Market Forecast
by Market Segment
U.S.A., All Market Segments Blood Typing
And Grouping Reagent Market Forecast
by Market Segment
U.S.A., Hospital Blood Banks Blood Typing
And Grouping Reagent Market Forecast
by Major Test
U.S.A., Community and Regional Blood Centers
Blood Typing and Grouping Reagent Market Forecast
By Major Test
U.S.A., Commercial/Private Laboratories
Blood Typing and Grouping Reagent Market Forecast
By Major Test
U.S.A., Plasma Fractionation Centers
Blood Typing and Grouping Reagent Market Forecast
By Major Test
U.S.A., Military Blood Banks Blood Typing
And Grouping Reagent Market Forecast by Major Test
U.S.A., All Market Segments Infectious
Disease Screening Reagent Market by Market Forecast
Segment
U.S.A., All Market Segments Infectious
Disease Screening Reagent Market by Market Forecast
Segment
U.S.A., Community and Regional Centers
Infectious Disease Screening Reagent Market Forecast
By Test
U.S.A., Plasma Fractionation Centers
Infectious Disease Screening Reagent Market Forecast
By Test
(continues)
U.S.A., Hospital Blood Banks
Infectious Disease Screening Reagent Market Forecast
By Test
U.S.A., Military Blood Banks Infectious
Disease Screening Reagent Market Forecast
By Test
U.S.A., Major Suppliers of Blood Typing
And Grouping Reagents Estimated Sales
And Market Shares
U.S.A., HIV/HTLV Blood Screening Market,
Reagent Sales by Major Supplier
U.S.A., Hepatitis Blood Screening Market,
Reagents Sales by Major Supplier
U.S.A., Hepatitis C Blood Screening Market,
Reagent Sales By Major Supplier
U.S.A., HIV/Hepatitis C NAT Market, Reagent
Sales By Major Supplier
U.S.A., West Nile Virus NAT Market,
Reagent Sales by Major Supplier
U.S.A., CMV Blood Screening Market,
Reagent Sales by Major Supplier
U.S.A., Syphilis Blood Screening Market,
Reagent Sales by Major Supplier

Fill The Form For Sample Request

Full Name *

Business Email *

E-mail *

Country * Select Country Albania Algeria Afghanistan Angola Argentina Armenia Aruba Australia Austria Azerbaijan Andorra Anguilla Bahrain Bangladesh Barbados Belarus Belgium Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Bosnia Cambodia Cameroon Central African Republic Chad Chile China Colombia Comoros Congo (Brazzaville) Cook Islands Costa Rica Cote d Ivoire Croatia Cuba Cyprus Czech Republic Cayman Islands Denmark Djibouti Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Gibraltar Greece Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Herzegovina Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Korea Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Lithuania Luxembourg Liechtenstein Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Middle East & North Africa (MENA) Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria North Korea Norway Oman Pakistan Palau Palestinian Territories Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Palestine Qatar Romania Russia Rwanda Samoa Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Korea Spain Sri Lanka Saint Kitts and Nevis Saint Vincent and the Grenadines Sudan Suriname Swaziland Sweden Switzerland Syria Scotland San Marino Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States of America Uruguay Uzbekistan Uraguay Vanuatu Venezuela Vietnam Virgin Islands Yemen Zambia Zimbabwe Canada Grenada Cape Verde Belize Curacao Republic of Srpska Antigua and Barbuda Saint Lucia Falkland Islands Faroe Islands Federated States of Micronesia Guadeloupe Martinique Montserrat Niue

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available